BackBluejay Diagnostics Overview

Bluejay Diagnostics Accounts Payable

Track Bluejay Diagnostics's accounts payable ($220K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$220288.00
57.60% YoYΔ $-299236.00 vs prior year quarter

Peer average / median

Loading

Bluejay Diagnostics Accounts Payable History

Loading

Bluejay Diagnostics vs. peers: Accounts Payable Comparison

Loading

Bluejay Diagnostics Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Bluejay Diagnostics (BJDX) FAQ

Bluejay Diagnostics posts a accounts payable of $220K as of March 2026. That compares with $520K in the prior-year period — down 57.6% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Bluejay Diagnostics's accounts payable was $520K. The latest reading is $220K — a 57.6% year-over-year decrease (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

Accounts Payable is one piece of Bluejay Diagnostics's financial statement story. At $220K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for BJDX's accounts payable usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Bluejay Diagnostics's other metric pages and overview cover the third.